Should you buy Aphria (TSX:APHA) on the dip?

August was looking like it would be a very good month for Aphria (TSX:APHA)(NYSE:APHA) after the stock soared on a good earnings report. However, since then, the stock has faltered, and it has dropped in value along with other cannabis stocks.
On Monday, Aphria’s stock closed at $8.45 — a big fall from the high of more than $10 a share that it reached earlier in the month. For investors, it could be a good opportunity to get back in at a lower price. After all, nothing has changed from the start of the month to the end that has drastically made Aphria a worse investment.
Valuation still looks decent
Aphria is not as overpriced as some of its peers, and with the decline in value, it might be a less risky investment overall. At around 1.2 times book value and nine times its sales, those are some modest multiples in an industry that’s been dominated by astronomical valuations.
One of the reasons for that, however, is that the stock has just not seen the same excitement that a stock like Canopy Growth has. Aphria has, unfortunately, provided investors with less-than-impressive returns, and that’s why it hasn’t had to come down a lot in price to be an appealing value today.
Why it’s a great opportunity to buy the stock
The company’s latest earnings report helped to re-establish Aphria as one of the top stocks in the industry. With strong sales growth and a profitable bottom line, it has attracted the attention of investors in a way that we haven’t seen in a while.
When also taking into consideration that recent struggles that Canopy Growth has faced, there could be a real opportunity for Aphria to move up the totem pole. While it would take a lot for investors to ditch Canopy Growth and buy Aphria instead, there’s going to be more of an appetite for that than there may have been in the past. Especially with poor earnings and a whole lot of uncertainty weighing Canopy Growth down as of late.
Pot stocks normally move together, as the general outlook for the industry can play a big role in whether stocks like Aphria or Canopy Growth rise in value. Even if the companies are doing well, if investors are concerned about the outlook for marijuana, it may not matter. Currently, we’re in a down cycle, but once things pick up again, perhaps as edibles get closer to launching, we could see another wave, which could send Aphria stock back up over $10.
Bottom line
Even though Aphria stock rallied earlier in the month, its share price has still taken a beating this year, as it’s down around 36% year to date. However, with the strong earnings and the stock generally seeing strong support at around $8 a share, it could prove to be a safe bet at its current price. While there’s always a risk that it could go lower, it seems unlikely to do so given the positivity around the stock today.
420 Intel is Your Source for Marijuana News
420 Intel Canada is your leading news source for the Canadian cannabis industry. Get the latest updates on Canadian cannabis stocks and developments on how Canada continues to be a major player in the worldwide recreational and medical cannabis industry.
420 Intel Canada is the Canadian Industry news outlet that will keep you updated on how these Canadian developments in recreational and medical marijuana will impact the country and the world. Our commitment is to bring you the most important cannabis news stories from across Canada every day of the week.
Marijuana industry news is a constant endeavor with new developments each day. For marijuana news across the True North, 420 Intel Canada promises to bring you quality, Canadian, cannabis industry news.
You can get 420 Intel news delivered directly to your inbox by signing up for our daily marijuana news, ensuring you’re always kept up to date on the ever-changing cannabis industry. To stay even better informed about marijuana legalization news follow us on Twitter, Facebook and LinkedIn.